🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 12

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 12 of 12
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jun 1, 2025 at 6:36 AM#56
EndoResFellow said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Jun 1, 2025 at 10:36 AM
33 6steve_okc, dave_SLC, FDA_TrackerJim and 30 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jun 8, 2025 at 1:20 AM#57

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Jun 8, 2025 at 2:20 AM
34 7Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 31 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Jun 14, 2025 at 8:00 PM#58

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

35 8LibrarianMeg, bri_stats, pete_manc_UK and 32 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 21, 2025 at 2:36 PM#59
BiostatsBrad said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Pushing back on BiostatsBrad here. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

36 9FitDadDave, RunnerRach, TrialNerd_Beth and 33 others
Reply Quote Save Share Report
oliver_london
Member
312
1,345
Aug 2024
London, UK
Jun 28, 2025 at 9:09 AM#60
BiostatsBrad said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

8 6wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 5 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register